NCT01187810 2022-03-31Fenretinide in Children With Recurrent/Resistant ALL, AML, and NHLSouth Plains Oncology ConsortiumPhase 1 Terminated3 enrolled
NCT00104923 2017-07-19Fenretinide in Treating Patients With Refractory or Relapsed Hematologic CancerCalifornia Cancer ConsortiumPhase 1 Completed29 enrolled